Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Eris Lifesciences Limited
  6. Summary
    540596   INE406M01024

ERIS LIFESCIENCES LIMITED

(540596)
  Report
End-of-day quote Bombay Stock Exchange  -  2023-05-29
630.85 INR   -0.70%
05/17Transcript : Eris Lifesciences Limited, Q4 2023 Earnings Call, May 17, 2023
CI
05/17Eris Lifesciences' Consolidated Profit Falls in Fiscal Q4
MT
05/17Eris Lifesciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
05/24/2023 05/25/2023 05/26/2023 05/29/2023 05/30/2023 Date
619.9 621.3 628.7 635.3 630.85 Last
1098 407 630 603 862 Volume
-0.06% +0.23% +1.19% +1.05% -0.70% Change
Estimated financial data (e)
Sales 2023 16 921 M 205 M 205 M
Net income 2023 3 934 M 47,6 M 47,6 M
Net Debt 2023 10 767 M 130 M 130 M
P/E ratio 2023 22,0x
Yield 2023 1,02%
Sales 2024 20 383 M 247 M 247 M
Net income 2024 4 247 M 51,4 M 51,4 M
Net Debt 2024 2 458 M 29,7 M 29,7 M
P/E ratio 2024 20,3x
Yield 2024 1,20%
Capitalization 85 798 M 1 038 M 1 038 M
EV / Sales 2023 5,71x
EV / Sales 2024 4,33x
Nbr of Employees 3 400
Free-Float 21,5%
More Financials
Company
Eris Lifesciences Limited is an India-based company that is primarily engaged in the manufacturing and marketing of pharmaceutical products. The Company’s manufacturing plant located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals and nutrients (VMN). The Company's brands include... 
Read more
Sector
Pharmaceuticals
Calendar
08/09Earnings Release
More about the company
Ratings of Eris Lifesciences Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about ERIS LIFESCIENCES LIMITED
05/17Transcript : Eris Lifesciences Limited, Q4 2023 Earnings Call, May 17, 2023
CI
05/17Eris Lifesciences' Consolidated Profit Falls in Fiscal Q4
MT
05/17Eris Lifesciences Limited Reports Earnings Results for the Fourth Quarter and Full Year..
CI
04/11India's Glenmark Pharma weighs selling stake in Glenmark Life - Mint
RE
03/27Eris Lifesciences Completes Acquisition of Nine Dermatology Brands from Dr. Reddy's
MT
03/24Eris Lifesciences Limited (NSEI:ERIS) completed the acqu..
CI
03/21Eris Lifesciences Moves Up Completion Date for Acquisition of Nine Dermatology Brands ..
MT
03/16Indian Equities Swing Between Losses, Gains as Investors Worry About New Banking Crisis
MT
03/16Transcript : Eris Lifesciences Limited - Shareholder/Analyst Call
CI
03/16India's Eris buys nine dermatology brands from Dr. Reddy's for $33 million
RE
03/16Eris Lifesciences to Acquire Nine Dermatology Brands from Dr. Reddy's
MT
03/16Dr. Reddy's Laboratories Limited, Eris Lifesciences Limited - M&A Call
CI
03/16Eris Lifesciences Limited (NSEI:ERIS) agreed to acquire ..
CI
03/10DocPlix Solutions Private Limited announced that it has received INR 50 million in fund..
CI
01/17Indian shares set to open higher; FIIs turn net buyers
RE
More news
News in other languages on ERIS LIFESCIENCES LIMITED
05/17Le bénéfice consolidé d'Eris Lifesciences chute au quatrième trimestre fiscal
05/17Eris Lifesciences Limited publie ses résultats pour le quatrième trimestre et l'exercic..
03/27Eris Lifesciences achève l'acquisition de neuf marques dermatologiques de Dr. Reddy's
03/24Eris Lifesciences Limited (NSEI:ERIS) a finalisé l'acqui..
03/21Eris Lifesciences avance la date d'achèvement de l'acquisition de neuf marques dermatol..
More news
ETFs positioned on ERIS LIFESCIENCES LIMITEDETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Vanguard FTSE All-World ex-US Small-Cap ETF - USD0.02%-1.76%World
WisdomTree India Earnings Fund - USD0.01%2.36%India
Vanguard ESG Emerging Market All Cap UCITS ...0.01%-0.96%-NC
Vanguard ESG Emerging Market All Cap UCITS ...0.01%-0.93%-NC
Vanguard FTSE Emerging Markets ETF - USD0.01%-0.10%China
More ETFs positioned on ERIS LIFESCIENCES LIMITED
Chart ERIS LIFESCIENCES LIMITED
Duration : Period :
Eris Lifesciences Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERIS LIFESCIENCES LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 630,90 INR
Average target price 785,00 INR
Spread / Average Target 24,4%
EPS Revisions
Managers and Directors
Amit Indubhushan Bakshi Chairman & Managing Director
Vijay S. Joshi President
Sachin Shah Senior Manager-Finance & Processes
Krishnakumar Vaidyanathan Chief Operating Officer & Executive Director
Milind Talegaonkar Secretary & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
ERIS LIFESCIENCES LIMITED-2.27%1 048
JOHNSON & JOHNSON-12.62%431 789
ELI LILLY AND COMPANY16.39%404 191
NOVO NORDISK A/S21.28%366 894
MERCK & CO., INC.0.11%281 833
ROCHE HOLDING AG0.07%259 852
-40% off: Our subscriptions help you unlock hidden opportunities!
Subscribe
fermer